Original Article
International Journal of Obesity (2007) 31, 871–875. doi:10.1038/sj.ijo.0803479; published online 17 October 2006
Does increased body mass index with hepatic steatosis contribute to seroclearance of hepatitis B virus (HBV) surface antigen in chronic HBV infection?
C-M Chu1, D-Y Lin1 and Y-F Liaw1
1Liver Research Unit, Chang Gung Memorial Hospital, Chang Gung University, Taipei, Taiwan
Correspondence: Professor C-M Chu, Liver Research Unit, Chang Gung Memorial Hospital, Chang Gung University, 199, Tung Hwa North Road, Taipei 10591, Taiwan. E-mail: chiamingchu@yahoo.com.tw
Received 30 March 2006; Revised 13 June 2006; Accepted 21 June 2006; Published online 17 October 2006.
Abstract
Background:
Overweight and hepatic steatosis have been increasingly recognized recently. This study aimed to test whether substantial amount of fatty infiltration in liver, which may interfere with cytoplasmic distribution of hepatitis B surface antigen (HBsAg), can contribute to HBsAg seroclearance in HBsAg carriers.
Methods:
Clinical and laboratory data including ultrasound grading of hepatic steatosis were studied in 54 HBsAg carriers with HBsAg seroclearance, and the results were compared with 108 age- and sex-matched carriers with HBsAg persistence.
Results:
Body mass index and ultrasound grading of hepatic steatosis were significantly higher in HBsAg carriers with HBsAg seroclearance than in those with HBsAg persistence. The degrees of hepatic steatosis correlated significantly with body mass index (P<0.001). The prevalence of mild hepatic steatosis showed no significant difference (33% (18/54) vs 31% (33/108), P=0.72), but moderate–severe hepatic steatosis was significantly more prevalent in patients with HBsAg seroclearance (33% (18/54) vs 13% (17/108), P=0.01). HBsAg carriers with moderate and severe hepatic steatosis were associated with a 3.2-fold (95% confidence interval: 1.2–8.4, P=0.02) and 3.9-fold (95% confidence interval: 1.1–14.2, P=0.04), respectively, increased odds of HBsAg seroclearance compared to those without hepatic steatosis.
Conclusion:
Moderate–severe hepatic steatosis may contribute to HBsAg seroclearance in HBsAg carriers.
Keywords:
body mass index, hepatic steatosis, HBsAg carriers, HBsAg seroclearance
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
RESEARCH
Synthesis and metabolism of cysteinyl leukotrienes by the isolated pig kidney
Kidney International Original Article
International Journal of Obesity Original Article
Impact of acute hepatitis B virus superinfection on chronic hepatitis c virus infection
American Journal of Gastroenterology Correspondence
Bright Liver and Alanine Aminotransferase Are Associated with Metabolic Syndrome in Adults **
Obesity Research Original Article
